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ABSTRACT
The incidence of melanoma is increasing rapidly in the United States. Sentinel lymph
node biopsy is an important diagnostic tool in the treatment and staging of melanoma. However,
many patients with melanoma will have had lymph node surgery for previous melanoma or
breast cancer. We set out to examine alterations in drainage patterns in patients with previous
axillary dissection for breast cancer. We reviewed four patients with truncal and/or extremity
melanomas and examined their lymphoscintigraphy and drainage patterns. Three patients with
truncal melanoma mapped to cervical lymph nodes and a fourth patient with an arm melanoma
mapped to her previously dissected axilla. Sentinel lymph node mapping is still an important
adjunct in patients with melanoma despite previous axillary dissection.

INTRODUCTION
Cutaneous melanoma, a malignancy of melanocytes, has been rapidly increasing in
incidence over the past 30 years (1). In 2010, there was an estimated 68,000 new cases of
melanoma and nearly 9000 melanoma-associated deaths (1). The staging, prognosis, and
treatment algorithms of melanoma depend on the Breslow thickness, mitoses, and the presence
or absence of regional and/or distant metastases (2). Melanoma preferentially spreads via the
lymphatics, and metastases typically progress through afferent lymphatic channels to sentinel
nodes before presenting in non-sentinel lymph node sites. The presence of malignancy in
regional lymph nodes carries a high prognostic significance, lowering the 5-year survival rate to
50% (3). Therefore, SLNB is of paramount importance in the initial workup and subsequent
management of cutaneous melanoma.
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We report 4 patients who presented with melanoma of either the upper limb or upper
posterior trunk; each of the patients had a history of breast cancer treated via surgical resection,
including axillary lymph node dissection. For melanomas of the upper limb and posterior trunk,
the site of sentinel lymph nodes is the ipsilateral axilla 99% and 93% of the time, respectively
(5). If the axillary nodal basin is surgically removed, as in the case of the 4 reported patients, the
lymphatic drainage may follow an alternate pathway with the sentinel nodes located in different
nodal basins. There is very little literature regarding sentinel lymph node localization in those
patients whose lymphatic drainage is significantly altered.
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METHODS
This is a retrospective case review of an IRB-approved melanoma data base. Upon
review, 4 patients were identified who had a history of a partial mastectomy with axillary node
dissection for the treatment of breast carcinoma and later presented with a cutaneous melanoma
in a location that classically drains to the axillary node basin. Each patient underwent
preoperatively lymphoscintigraphy to identify sentinel lymph nodes.

RESULTS
Patient No. 1
A 36-year-old female underwent bilateral mastectomies, including right axillary node
dissection in 1994 for right-sided breast carcinoma and. In April 2006, she presented with a 0.9
millimeter melanoma on her right forearm. After excision with 1cm margins, SLNB was
recommended; lymphoscintigraphy revealed a right axillary sentinel lymph node. Three sentinel
lymph nodes were identified just posterior to the thoracodorsal nerve. The final routine and
immunohistochemical stains of the lymph nodes were negative for melanoma.
Patient No. 2
A 38-year-old female underwent right modified radical mastectomy in 1981 for right-side
breast cancer. In November 2006, she presented with a pigmented lesion on her right upper back.
Biopsy was consistent with a malignant melanoma 0.5 millimeters in depth, Clark level IV. It
was decided to proceed with a wide local excision and SLNB. Preoperative lymphoscintigraphy
revealed a right supraclavicular lymph node. She underwent wide local excision of her
melanoma and removal of 2 cervical lymph nodes which were negative for melanoma.
Patient No. 3
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The third patient is a 79-year old female who previously underwent a left axillary
dissection for a left back melanoma. She also underwent a right partial mastectomy and axillary
lymph node dissection in 1999 for breast cancer. She presented in 2011 with a 3.7 mm thick,
nodular melanoma with ulceration on her right upper back. The patient was advised to proceed
with a wide local excision of the melanoma and SLNB. Preoperative lymphoscintigraphy
revealed a right supraclavicular sentinel lymph node. The patient underwent wide excision and
dissection of 2 cervical lymph nodes. The lymph nodes were negative for metastatic melanoma.
Patient No. 4
A 73-year-old female treated in 1994 for right breast cancer with a partial mastectomy
and axillary lymph node dissection. In November 2009, she presented with a lesion on her right
posterior shoulder with biopsy consistent with a 0.7 mm melanoma. Re-excision of the lesion
revealed an additional 4 mm of melanoma; SLNB was recommended. Lymphoscintigraphy
revealed a supraclavicular sentinel lymph node. Subsequently, the patient underwent excision of
two right-sided cervical lymph nodes which, on subsequent pathology were deemed to be free of
melanoma.

6

DISCUSSION
By definition, a sentinel lymph node is any lymph node that receives lymphatic drainage
directly from the primary tumor. Within a particular nodal basin, a sentinel node is the first node
to receive lymphatic drainage; therefore, the histology of the sentinel node if felt to be
representative of all other nodes in the basin (6). Historically, the only way to successfully
identify sentinel nodes was to perform a complete lymph node dissection and study the
pathology of each individual node within that basin. With the advent of cutaneous
lymphoscintigraphy in 1977, Fee and colleagues began to characterize lymphatic drainage
patterns of melanoma (7). In 1993, Alex and Krag introduced the concept of performing
lymphoscintigraphy with teachnetium-99m sulfur colloid followed by intraoperative use of a
handheld gamma probe for a more precise localization of sentinel nodes (8). Currently, preoperative lymphoscintigraphy, intraoperative intradermal injection of blue-dye and use of the
gamma probe are all used in conjunction to accurately identify sentinel nodes.
One of the most important prognostic factors for melanoma is the presence and/or
absence of malignancy in the regional lymph nodes draining the primary tumor (4). For this
reason, the use of lymphoscintigraphy and sentinel node biopsy (SNB) is routine practice in the
workup of patients presenting with a primary cutaneous melanoma. SNB is recommended for all
Stage Ia melanomas with adverse prognostic features (thickness > 0.75 mm, lymphovascular
invasion, positive deep margins, ulceration, and mitoses), Stage IB, Stage II, and in-transit
melanomas.
However, there is no clear consensus on how to investigate lymphatic metastases in those
patients with melanoma whose regional lymphatic basins have been surgically altered. There is
no recommendation to proceed with SNB when the lymph node basin that classically contains
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the sentinel node has already been removed. In fact, some advocate that if lymphatic channels
have been disrupted by previous surgery, lymphoscintigraphy is not indicated because nodes
may be falsely identified as being sentinel (9). However, with the technological advancements in
lymphatic mapping, it has become relatively common to detect sentinel nodes in nodal basins not
previous thought to receive lymphatic drainage directly from the tumor. Studies report
discordance between the drainage patterns identified via lymphoscintigraphy and the predicted
pattern in 32%-62% of cases of truncal melanoma (2). Therefore, removing the lymphatic basin
typically containing the sentinel node does not preclude the existence of sentinel nodes in other
atypical nodal basins. Moreover, when entire lymph node basins have been removed, the
lymphatic drainage patterns will alter their course to follow new and unexpected routes. In 2004,
Sood et al reported four patients with a history of breast carcinoma who underwent lumpectomy
and axillary lymph node dissection and subsequently developed recurrence in the same breast
(6). Each of the patients underwent lymphoscintigraphy in the workup of their cancer recurrence.
The results of lymphoscintigraphy showed altered lymphatic drainage patterns of the residual
breast tissue and different sentinel node locations (6).
Our experience yielded similar results, suggesting that the removal of classically located
sentinel lymph node basins does not preclude the existence of additional sentinel nodes. Results
from three out of four patients demonstrate that although lymphatic drainage of the trunk is often
to the axillary node basin, supraclavicular and cervical node basins may contain sentinel nodes
which are potential sites of metastatic disease. The lymphoscintigraphy results of Patient 1 show
that a sentinel node may even exist in what was previously felt to be completely dissected lymph
node basin. Given that lymphoscintigraphy is minimally invasive and relatively inexpensive, it is
a cost effective means to identify sentinel nodes and allow for an accurate biopsy. Based on our
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experience, lymphoscintigraphy and sentinel lymph node biopsy should be performed even if
traditional sentinel nodal basins have been removed.
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Figure Legends:
Figure 1- right upper back melanoma; anterior image obtained 15 minutes after radiotracer
injection shows a right supraclavicular lymph node (arrow) superior to the injection site .
Figure 2—posterior shoulder melanoma; anterior image obtained 5 minutes subsequent to
radiotracer injection demonstrates a right cervical sentinel lymph node (arrow) just lateral to the
projection of the injection site.

11

